Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1949 1
1951 1
1967 1
1971 1
1972 2
1974 2
1976 1
1977 1
1978 3
1979 1
1980 1
1981 2
1982 4
1983 3
1984 1
1985 4
1986 1
1987 4
1988 2
1990 3
1992 3
1993 1
1994 1
1995 3
1996 1
1997 3
1998 2
2000 2
2002 1
2003 2
2004 1
2005 1
2006 1
2007 5
2008 13
2009 15
2010 13
2011 8
2012 17
2013 13
2014 9
2015 5
2016 6
2017 3
2018 1
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
[Macrocephalia].
Mathieu JP, Décarie M, Leblanc P, Meloche BR. Mathieu JP, et al. Union Med Can. 1971 Jul;100(7):1346-50. Union Med Can. 1971. PMID: 5562192 French. No abstract available.
[Scleroderma].
Hébert J, Mathon G, Mathieu JP. Hébert J, et al. Among authors: mathieu jp. Union Med Can. 1981 Mar;110(3):209-20. Union Med Can. 1981. PMID: 7245418 French. No abstract available.
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group; Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group. Ferdowsi N, et al. Ann Rheum Dis. 2019 Jun;78(6):807-816. doi: 10.1136/annrheumdis-2018-214764. Epub 2019 Mar 30. Ann Rheum Dis. 2019. PMID: 30928903
Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis.
Hoa S, Bernatsky S, Baron M, Proudman S, Stevens W, Sahhar J, Wang M, Steele RJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Nikpour M, Hudson M. Hoa S, et al. Chest. 2021 Dec;160(6):2158-2162. doi: 10.1016/j.chest.2021.06.014. Epub 2021 Jun 18. Chest. 2021. PMID: 34153341 No abstract available.
159 results